PRESS RELEASES

The GeneStrat® Liquid Biopsy Test Earns Approval from NY State-CLEP

The GeneStrat® Liquid Biopsy Test Earns Approval from NY State-CLEP

Biodesix® Laboratory Also Certified by CAP, CLIA, ISO 35485 Biodesix, Inc. announced today that the GeneStrat test has been approved by New York State’s Clinical Laboratory Evaluation Program (CLEP). Approval for the GeneStrat test by CLEP is the most recent of...

Biodesix Presents Data From Three Studies at AACR Annual Meeting

New data on liquid biopsy genomic tests, including multiplexed genomic assays; evaluation of biological processes underlying mass spectrometry proteomic assays of human serum April 5, 2017, Boulder, Colorado… Biodesix is presenting three studies that support the...

Biodesix Announces Data To Be Presented at AACR Annual Meeting 2017

New data on genomic tests and single-reaction, multiplexed genomic assays; evaluation of biological processes via mass spectrometry of human serum March 28, 2017, Boulder, Colorado…Biodesix, Inc. will present three posters summarizing new data from research evaluating...

Biodesix® and Progenetics Announce Distribution Agreement for Israel

March 9, 2017, Boulder, Colorado…Biodesix, Inc. (Boulder, CO, USA) and Progenetics LTD (Tel Aviv, Israel) announced today that they have entered into an international agreement where Progenetics will market and distribute kits for Biodesix’s GeneStrat® and...

Blood-Based Diagnostic Assay Measures Immunotherapy Biomarker PD-L1

Blood-Based Diagnostic Assay Measures Immunotherapy Biomarker PD-L1 ddPCR Assay Measures mRNA Expressions from Immune and Cancer Cell; Key Step In Development of Immunotherapy Test New data from Biodesix® evaluating an assay in development demonstrated the potential...

VIEW OUR BLOGS

READ

HOME     CONTACT     TERMS & CONDITIONS     CAREERS     FAQ     SITE MAP     NEWS

ORDER A TEST KIT

CLICK HERE